SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Phillis Wheatley Synthetic CCD

PatientPhillis Wheatley
Date of birth2006-07-01
IdentifiersMRN HR-EN015-SYN; SSN (made up) 000-15-3360
Document date2026-11-01
AuthorAbena Hartley-Okonkwo, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Reason for Visit

New patient visit for three months of winter wheeze, cough and breathlessness in a 19-year-old woman called asthmatic since childhood and never tested: examination, chest X-ray, blood count, tuberculosis and pregnancy tests, and planning of lung function testing; trauma-informed social history. Concerns: Her chest is worse every winter, and cough at night keeps her from sleeping and writing; She may soon travel by sea to see her book published abroad, and wants to be well enough to go; She wants her care to be her own: her consent, her information, and her decisions. [S]

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Medications

MedicationFrequencyRouteDatesStatusEvidence
Budesonide-formoterol 160/4.5 mcg inhaler as needed only (GINA track 1, step 2, anti-inflammatory reliever): one inhalation whenever needed for symptoms or before exercise in the cold, no more than 12 inhalations a dayOne inhalation as neededRespiratory tract route2026-02-23 to 2026-09-21completedS
Prednisone 20 mg oral tablet, standby course for the sea journey and the summer away: two tablets (40 mg) each morning for five days, to start only as her action plan directs40 mg each morning for five days if the action plan directsOral route2026-04-06 to 2026-10-26stoppedS
Meclizine 25 mg oral tablet, one tablet an hour before sailing and then once daily as needed for seasicknessOne tablet daily as needed at seaOral route2026-04-06 to 2026-09-21completedS
Folic acid 0.4 mg oral tablet, one tablet dailyOne tablet dailyOral route2026-04-27activeS
Budesonide-formoterol 160/4.5 mcg inhaler as maintenance and reliever (GINA track 1, step 3): one inhalation twice daily and one inhalation as needed, no more than 12 inhalations a dayOne inhalation twice daily plus one as neededRespiratory tract route2026-09-21activeS

Procedures

ProcedureDatesStatusEvidence
Chest X-ray, posteroanterior and lateral: lungs clear and not hyperinflated; no consolidation, hilar enlargement, cavity, scarring or effusion; heart size normal2026-02-09 to 2026-02-09completedS
Spirometry before and 15 minutes after albuterol 400 mcg, with FeNO, interpreted with GLI Global race-neutral equations: FEV1 2.24 L (83 percent predicted) rising to 2.57 L (+330 mL, +15 percent); FEV1/FVC 0.72 before (below the lower limit of normal of 0.75) and 0.80 after; FeNO 38 ppb. Reversible airflow obstruction: asthma2026-02-23 to 2026-02-23completedS
Written asthma action plan, given and explained: green zone use the reliever as needed; yellow zone (more symptoms, waking, or peak flow below 80 percent of her best) use more reliever inhalations up to 12 a day and call the clinic; red zone (peak flow below 50 percent, cannot speak in sentences, or no relief) emergency care. Peak flow meter given; zones to be set from her personal best2026-02-23 to 2026-02-23completedS
Inhaler technique with her new pressurized inhaler and a spacer: taught and checked by teach-back; correct2026-02-23 to 2026-02-23completedS
Asthma action plan updated for travel: peak flow zones set from her personal best of 400 L/min (green above 320, yellow 200 to 320, red below 200); instructions for the standby prednisone course and for finding care at sea and abroad; a printed medical summary2026-04-06 to 2026-04-06completedS
Advance care planning conversation, about 16 minutes, with her consent2026-04-27 to 2026-04-27completedS
Spirometry before bronchodilator after recovery: FEV1 2.45 L (91 percent predicted); FEV1/FVC 0.78; FeNO 24 ppb2026-10-26 to 2026-10-26completedS
Asthma action plan updated for maintenance-and-reliever therapy through the winter (green above 320 L/min, yellow 200 to 320, red below 200)2026-10-26 to 2026-10-26completedS

Immunizations

DateVaccineStatusEvidence
2018-09-04Tdap vaccine (from her school record)completedS
2026-02-23Influenza vaccine, this seasoncompletedS
2026-02-23COVID-19 mRNA vaccine, this season's formulacompletedS
2026-02-23Pneumococcal conjugate vaccine PCV20completedS
2026-04-27Human papillomavirus vaccine (9-valent), dose 1 of 3completedS
2026-04-27Hepatitis B vaccine (HepB-CpG), dose 1 of 2completedS
2026-10-26Hepatitis B vaccine (HepB-CpG), dose 2 of 2completedS
2026-10-26Human papillomavirus vaccine (9-valent), dose 2 of 3completedS
2026-10-26Influenza vaccine, the new seasoncompletedS
2026-10-26COVID-19 mRNA vaccine, the new season's formulacompletedS

Past Medical History

Historical biography with true dates. These events are not part of the synthetic care timeline.

Historical dateHistoryEvidence
1761Described as a slender, frail child on her arrival in Boston at about seven, and by one reference work as asthmatic; no symptoms, triggers or treatment recordedD (CLM-0003)

Family History

No family medical history is documented in the logged sources. Family history of real relatives is recorded only from documented or retrospective sources and is never synthesized.

Health Concerns

ConcernStatusEvidence
Her chest is worse every winter, and cough at night keeps her from sleeping and writingactiveS
She may soon travel by sea to see her book published abroad, and wants to be well enough to goactiveS
She wants her care to be her own: her consent, her information, and her decisionsactiveS

Assessment

Most recent measures: Hemoglobin [Mass/volume] in Blood 12.6 on 2026-02-09; Leukocytes [#/volume] in Blood by Automated count 7.2 on 2026-02-09; Eosinophils [#/volume] in Blood by Automated count 0.38 on 2026-02-09; Platelets [#/volume] in Blood by Automated count 284 on 2026-02-09; Total score [ACT] 20 on 2026-10-26; Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 0 on 2026-10-26; Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 4 on 2026-04-27; Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] 3 on 2026-04-27; Maximum expiratory gas flow Respiratory system airway by Peak flow meter 385 on 2026-10-26; FEV1 --pre bronchodilation 2.45 on 2026-10-26; FEV1 --post bronchodilation 2.57 on 2026-02-23; FEV1 measured/predicted 91 on 2026-10-26; FEV1/FVC 0.78 on 2026-10-26; FEV1/FVC --post bronchodilation 0.8 on 2026-02-23; Fractional concentration of exhaled nitric oxide 24 on 2026-10-26; IgE [Units/volume] in Serum or Plasma 165 on 2026-02-23 [S]

Strengths and supports: engagement in care [S]

Problems

ProblemClinical statusVerificationCodeProvenance
Wheeze, cough and breathlessness this winter, for about three months: symptoms on three or four days a week, waking with cough and a tight chest about twice a month, breathless climbing the hill streets in cold air; worse with cold wind, kitchen and fireplace smoke, and colds; called a weak chest and asthma since childhood but never tested or treated. Asthma to be confirmed with spirometry before and after bronchodilator and FeNOresolvedconfirmed R06.2S — Synthetic presenting problem anchored to her documented frail, asthmatic childhood. Superseded by the diagnosis at the second visit.
Asthma, confirmed, mild persistent: variable airflow obstruction (FEV1/FVC 0.72, below the lower limit of normal, rising to 0.80 after bronchodilator; FEV1 2.24 L, 83 percent predicted, rising 330 mL or 15 percent); type 2 inflammation (FeNO 38 ppb, blood eosinophils 0.38 x10^3/uL, total IgE 165, house dust mite sensitization); tuberculosis infection test negative and chest X-ray clear. Triggers: cold air, kitchen and fireplace smoke, coldsactiveconfirmed J45.30S — Synthetic modern confirmation linked to her documented frail, asthmatic childhood and her own later descriptions of asthma.
Asthma exacerbation with a cold a week after returning from abroad: three days of wheeze, chest tightness and waking at night despite six to eight reliever inhalations a day; peak flow 270 L/min (68 percent of her best of 400), oxygen saturation 96 percent; 330 L/min after treatment in clinic; treated without oral corticosteroids; resolvedresolvedconfirmed J45.31S — Synthetic exacerbation anchored to her own letter describing a cold and asthma after her return; the clinical details are synthetic.
Prone to seasickness on boat trips; meclizine for the sea crossing; resolved on her returnresolvedconfirmed T75.3XXAS — Synthetic travel-related problem.
Pregnancy planning: not sexually active and no contraception wanted now; she may wish to have children one day; folic acid by her choice, and asthma care planned before and during any pregnancyactiveconfirmed Z31.69S — Synthetic reproductive health counselling; not a claim about her real life.

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-02-09Hemoglobin [Mass/volume] in Blood12.6g/dL12-15.5 g/dLNormalS
2026-02-09Leukocytes [#/volume] in Blood by Automated count7.210*3/uL4-11 10*3/uLNormalS
2026-02-09Eosinophils [#/volume] in Blood by Automated count0.3810*3/uL0-0.5 10*3/uLNormalS
2026-02-09Platelets [#/volume] in Blood by Automated count28410*3/uL150-400 10*3/uLNormalS
2026-02-09Total score [ACT]15{score}S
2026-02-09Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]1{score}S
2026-04-27Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]4{score}S
2026-04-27Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ]3{score}S
2026-09-21Maximum expiratory gas flow Respiratory system airway by Peak flow meter270L/min80 percent of her personal best of 400 L/minLowS
2026-02-23FEV1 --pre bronchodilation2.24LLower limit of normal; predicted 2.70 L; lower limit of normal 2.17 L (GLI Global race-neutral equations)NormalS
2026-02-23FEV1 --post bronchodilation2.57LLower limit of normal; predicted 2.70 L; lower limit of normal 2.17 L (GLI Global race-neutral equations)NormalS
2026-02-23FEV1 measured/predicted83%GLI Global race-neutral equationsNormalS
2026-02-23FEV1/FVC0.72{ratio}Lower limit of normal for her age (GLI Global)LowS
2026-02-23FEV1/FVC --post bronchodilation0.8{ratio}Lower limit of normal for her age (GLI Global)NormalS
2026-02-23Fractional concentration of exhaled nitric oxide38[ppb]Above 50 ppb high; 25 to 50 intermediate (ATS)HighS
2026-02-23IgE [Units/volume] in Serum or Plasma165[IU]/mL<=100 [IU]/mLHighS
2026-02-23Total score [ACT]16{score}S
2026-04-06Total score [ACT]21{score}S
2026-04-06Maximum expiratory gas flow Respiratory system airway by Peak flow meter400L/min80 percent of her personal best of 400 L/minNormalS
2026-10-26Total score [ACT]20{score}S
2026-10-26FEV1 --pre bronchodilation2.45LLower limit of normal; predicted 2.70 L; lower limit of normal 2.17 L (GLI Global race-neutral equations)NormalS
2026-10-26FEV1 measured/predicted91%GLI Global race-neutral equationsNormalS
2026-10-26FEV1/FVC0.78{ratio}Lower limit of normal for her age (GLI Global)NormalS
2026-10-26Fractional concentration of exhaled nitric oxide24[ppb]Above 50 ppb high; 25 to 50 intermediate (ATS)NormalS
2026-10-26Maximum expiratory gas flow Respiratory system airway by Peak flow meter385L/min80 percent of her personal best of 400 L/minNormalS
2026-10-26Patient Health Questionnaire 2 item (PHQ-2) total score [Reported]0{score}S

Social History

Vital Signs

DateMeasureValueUnitProvenance
2026-02-09Body height152cmS
2026-02-09Body weight45.6kgS
2026-02-09Body mass index (BMI) [Ratio]19.7kg/m2S
2026-02-09Systolic blood pressure104mm[Hg]S
2026-02-09Diastolic blood pressure66mm[Hg]S
2026-02-09Heart rate86/minS
2026-02-09Respiratory rate18/minS
2026-02-09Body temperature36.7CelS
2026-02-09Oxygen saturation in Arterial blood by Pulse oximetry97%S
2026-02-23Body height152cmS
2026-02-23Body weight45.8kgS
2026-02-23Body mass index (BMI) [Ratio]19.8kg/m2S
2026-02-23Systolic blood pressure106mm[Hg]S
2026-02-23Diastolic blood pressure66mm[Hg]S
2026-02-23Heart rate82/minS
2026-02-23Respiratory rate16/minS
2026-02-23Body temperature36.6CelS
2026-02-23Oxygen saturation in Arterial blood by Pulse oximetry98%S
2026-04-06Body height152cmS
2026-04-06Body weight46.4kgS
2026-04-06Body mass index (BMI) [Ratio]20.1kg/m2S
2026-04-06Systolic blood pressure104mm[Hg]S
2026-04-06Diastolic blood pressure64mm[Hg]S
2026-04-06Heart rate76/minS
2026-04-06Respiratory rate14/minS
2026-04-06Body temperature36.6CelS
2026-04-06Oxygen saturation in Arterial blood by Pulse oximetry99%S
2026-04-27Body height152cmS
2026-04-27Body weight46.6kgS
2026-04-27Body mass index (BMI) [Ratio]20.2kg/m2S
2026-04-27Systolic blood pressure102mm[Hg]S
2026-04-27Diastolic blood pressure64mm[Hg]S
2026-04-27Heart rate74/minS
2026-04-27Respiratory rate14/minS
2026-04-27Body temperature36.6CelS
2026-04-27Oxygen saturation in Arterial blood by Pulse oximetry99%S
2026-09-21Body height152cmS
2026-09-21Body weight47.2kgS
2026-09-21Body mass index (BMI) [Ratio]20.4kg/m2S
2026-09-21Systolic blood pressure108mm[Hg]S
2026-09-21Diastolic blood pressure68mm[Hg]S
2026-09-21Heart rate98/minS
2026-09-21Respiratory rate20/minS
2026-09-21Body temperature37.6CelS
2026-09-21Oxygen saturation in Arterial blood by Pulse oximetry96%S
2026-10-26Body height152cmS
2026-10-26Body weight47.6kgS
2026-10-26Body mass index (BMI) [Ratio]20.6kg/m2S
2026-10-26Systolic blood pressure104mm[Hg]S
2026-10-26Diastolic blood pressure66mm[Hg]S
2026-10-26Heart rate74/minS
2026-10-26Respiratory rate14/minS
2026-10-26Body temperature36.5CelS
2026-10-26Oxygen saturation in Arterial blood by Pulse oximetry99%S

Encounters

DatePurposeStatusProvenance
2026-02-09New patient visit for three months of winter wheeze, cough and breathlessness in a 19-year-old woman called asthmatic since childhood and never tested: examination, chest X-ray, blood count, tuberculosis and pregnancy tests, and planning of lung function testing; trauma-informed social historyfinishedS
2026-02-23Diagnosis visit: spirometry with bronchodilator response and FeNO with the pulmonology consultation; asthma confirmed; start of as-needed budesonide-formoterol (GINA track 1); action plan; vaccinesfinishedS
2026-04-06Six-week asthma review: control, technique, personal best peak flow, triggers, and planning for a long sea journey and a summer awayfinishedS
2026-10-26Asthma review after an exacerbation with a cold on her return from abroad: control, repeat spirometry and FeNO, the winter plan, completion of vaccines, and her changed circumstancesfinishedS
2026-04-27Periodic preventive visit before a long sea journeyfinishedS
2026-09-21Same-day sick visit for asthma with a cold after returning from abroadfinishedS

Plan of Treatment

InterventionStatusGuidelineProvenance
Pulmonology consultation in two weeks with spirometry before and after bronchodilator and FeNO, to confirm or refute asthma, exclude other chest disease, and plan treatment and preparation for travelcompletedGL-GINA-2025, GL-NAEPP-2020, GL-CMID-2026S
Work-up of wheeze and cough: chest X-ray, blood count with eosinophils, interferon-gamma release assay for tuberculosis infection (born in a country where tuberculosis is common), and a urine pregnancy test before treatment; no inhaler is started before testing unless symptoms worsencompletedGL-GINA-2025, GL-USPSTF-LTBI-2023S
Trauma-informed, patient-centred care: seen alone for part of every visit; consent, information and results to her alone, through her own contact details; no instructions about her care accepted from the household; private screening for safety and exploitation at each visit, with resources and social work offered and her decisions respectedcompletedGL-ACOG-TRAFFICKING-2019, GL-USPSTF-IPV-2025S
Equity safeguards: spirometry read with race-neutral GLI Global equations, plain explanation of every result, and attention to the higher asthma burden carried by Black womencompletedGL-ATS-RACE-2023, GL-MMWR-ASTHMA-2021S
GINA track 1, step 2: as-needed low-dose budesonide-formoterol (no albuterol-only reliever), a written action plan with peak flow zones, technique checks and trigger reduction (kitchen ventilation, avoiding fireplace smoke, a scarf in cold wind, mite-proof bedding); review six weeks after starting and within a week of any exacerbationcompletedGL-GINA-2025, GL-NAEPP-2020, GL-CMID-2026S
Vaccines for an adult with asthma: influenza and COVID-19 each season, and PCV20 oncecompletedGL-CDC-IMZ-MC-2026, GL-CDC-IMZ-2026S
Travel plan for a long sea journey: two inhalers and a spacer, an updated action plan, a standby five-day prednisone course with clear start rules, meclizine for seasickness, an aired cabin away from smoke, a printed medical summary and contact with the clinic by messagecompletedGL-GINA-2025, GL-CDC-YB-MOTIONS
Contraception and pregnancy planning on her terms: information on every method (all suitable with asthma), folic acid 0.4 mg daily by her choice, and asthma review before and during any pregnancy with budesonide as the preferred inhaled steroid and the controller never stoppedcompletedGL-CDC-MEC-2024, GL-ACOG-ASTHMA-2008, GL-USPSTF-FOLIC-2023S
After the exacerbation: GINA track 1 step 3, budesonide-formoterol one inhalation twice daily and as needed through the winter, with a step-down to as-needed treatment in the spring if she stays wellcompletedGL-GINA-2025, GL-CMID-2026S
Social work, at her request, for health coverage in her own name, income and housing after she gained her freedomcompletedGL-ACOG-TRAFFICKING-2019S

Goals

GoalTargetStatusOutcomeProvenance
A confirmed diagnosis within two weeks: spirometry with bronchodilator response and FeNO, with tuberculosis excluded2026-02-23completedAsthma confirmed by a 330 mL (15 percent) bronchodilator response and FeNO 38 ppb; tuberculosis test negative and chest X-ray clear, two weeks after the first visitS
Asthma Control Test 20 or more with no night waking2026-04-06completedAsthma Control Test 21 and no night waking six weeks after starting treatment; 20 after the exacerbationS
Correct inhaler technique and a written action plan she can use at home and at sea2026-04-06completedTechnique correct at every visit; plan used during the exacerbationS
Well enough to make the sea journey and spend the summer away2026-09-21completedTravelled and stayed well all summer without the standby prednisoneS
No exacerbation needing an oral corticosteroid2026-10-26completedAchieved: one exacerbation with a cold, managed with extra budesonide-formoterol and a step-up, without prednisoneS
Hepatitis B and HPV vaccination complete2027-01-25activeHepatitis B series complete; HPV dose 3 dueS

Functional Status

Mental Status